Constella: new treatment for constipation-predominant IBS

Linaclotide (Constella) is guanylate cyclase-C receptor agonist for the treatment of constipation-predominant IBS. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects and Dr Nigel Trudgill discusses its place in therapy.

Constella new treatment for constipation predominant IBS

Add yours ↓
Web design and marketing agency Leamington Spa